Evaluating a Digital Video-Based Game Exercise System ApneaTheraPlay for Adults with Obstructive Sleep Apnea Syndrome
Led by Medipol University · Updated on 2026-10-13
54
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating a new digital video-based game exercise platform called ApneaTheraPlay ATP for people with Obstructive Sleep Apnea Syndrome OSAS. The study aims to evaluate how combining respiratory, aerobic, strengthening, and oropharyngeal exercises before sleep may improve symptoms and support the effectiveness of CPAP therapy, which many patients find difficult to use consistently. This study addresses the lack of comprehensive programs that integrate multiple exercise types and tests their effect when performed right before bedtime.
Participants will be randomly assigned to one of three groups the ApneaTheraPlay ATP group, a structured pre-sleep exercise group SPEG, or a control group. The two exercise groups will complete 36 exercise sessions over 12 weeks, training three times per week with exercises lasting about 30 minutes each, including breathing, aerobic, strengthening, and oropharyngeal activities. The control group will maintain a physical activity diary and continue their prescribed CPAP use. After the study, control group participants will be offered access to the ATP system.
During the study, participants will be monitored through various assessments at the start, 12 weeks, and 24 weeks. Measurements include apnea-hypopnea index AHI, oxygen saturation, sleep quality and sleepiness questionnaires, lung function tests, muscle strength, fatigue, anxiety and depression scales, CPAP adherence, exercise compliance, and heart rate variability. The study also tracks daily steps and system usability. This comprehensive monitoring aims to assess the effects of the exercise programs on sleep apnea symptoms and overall health over time.
CONDITIONS
Brief Title
Development and Investigation of the ApneaTheraPlay
Research Team
G
Gülay Aras Bayram, PhD
G
Gülay Aras Bayram
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with mild, moderate, or severe obstructive sleep apnea syndrome (AHI 5-30 events/hour) based on polysomnography
Diagnosed by a pulmonologist within the last year and started CPAP therapy within the past 12 months with regular use
Habitual snoring
Access to a phone, tablet, or computer compatible with the exercise system app
Sufficient physical function to follow exercise instructions
Familiarity with mobile health apps and willingness to participate in exercises with a score above 7 on VAS
No physiotherapy-based interventions targeting OSAS in the last 3 months
Score of 68 or higher on the System Usability Scale (SUS)
You will not qualify if you...
Body mass index (BMI) greater than 40 kg/m2
Serious drug or alcohol abuse
Regular use of sedatives, muscle relaxants, or opioids that affect sleep or exercise
Pregnancy or postpartum less than 6 months
Medical contraindications to physical activity such as unstable coronary disease or decompensated heart failure
History of stroke
Significant respiratory, neuromuscular, or other disorders causing high carbon dioxide levels
Systemic inflammatory diseases like arthritis, sarcoidosis, vasculitis, or lupus
Craniofacial deformity
Secondary respiratory diseases such as severe upper airway obstruction or COPD
Presence of swallowing difficulties (dysphagia)
Tongue movement restriction due to a frenulum
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual)
Exercise Intervention
Duration - 12 weeks
Participants in the ApneaTheraPlay or structured pre-sleep exercise groups will perform breathing, aerobic, strengthening, and oropharyngeal exercises three times a week for 12 weeks. Control group participants will maintain a physical activity diary and continue CPAP use.
3 sessions per week (home-based exercises)
Follow-up Assessments
Duration - 24 weeks total from baseline
Researchers will evaluate sleep apnea symptoms, lung function, sleep quality, muscle strength, exercise compliance, and other health measures at 0, 12, and 24 weeks to monitor progress and effects.
Assessments at weeks 0, 12, and 24
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Evaluating a Digital Video-Based Game Exercise System ApneaTheraPlay for Adults with Obstructive Sleep Apnea Syndrome
Pilot Study of Aprepitant Taking to Lower Aldosterone in Adults with Severe Obstructive Sleep Apnea and High Blood Pressure
Evaluating Hypnosis to Improve Long-Term Use of CPAP Therapy for Sleep-Disordered Breathing
Early Physiotherapy for At-Risk Infants to Improve Motor Skills and Development
Health Effects of Exercise Addiction on Musculoskeletal and Cardiovascular Systems in Adult Recreational Gym Users
Women With Fibromyalgia Comparing Three Different Resistance Training Volumes
Randomized Crossover Clinical Trial
Evaluating Neuroscience-Based Exercise Training Versus Standard Exercises on Shooting and Neuromuscular Performance in Young Archers
The RECOVER Study How Pelvic Floor Heals After Vaginal Childbirth and the Impact of Early Personalized Muscle Training
Use of Measurement Tools by Physiotherapists in Clinical Practice in Turkiye to Understand Current Assessment Habits
Study to Validate the French Version of the OSA-18 Questionnaire in Children Aged 4 to 17 Years with Suspected Obstructive Sleep Apnea
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Development and investigation of the efficacy of an interactive, web-based game exercise system (ApnoeaTheraPlay) for individuals with obstructive sleep apnoea syndrome: study protocol for a randomised, single-blind, controlled trial.
Gulay Aras Bayram, Devrim Tarakci, Gizem Ergezen Sahin...